NL9200423A - Farmaceutische samenstelling die als aktieve ingredient 3-/2-(dimethylamino)-ethyl/-n-methyl-1h-indool-5-methaansulfonamide bevat. - Google Patents

Farmaceutische samenstelling die als aktieve ingredient 3-/2-(dimethylamino)-ethyl/-n-methyl-1h-indool-5-methaansulfonamide bevat. Download PDF

Info

Publication number
NL9200423A
NL9200423A NL9200423A NL9200423A NL9200423A NL 9200423 A NL9200423 A NL 9200423A NL 9200423 A NL9200423 A NL 9200423A NL 9200423 A NL9200423 A NL 9200423A NL 9200423 A NL9200423 A NL 9200423A
Authority
NL
Netherlands
Prior art keywords
pharmaceutical composition
active ingredient
methyl
indole
composition according
Prior art date
Application number
NL9200423A
Other languages
English (en)
Dutch (nl)
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NL9200423A publication Critical patent/NL9200423A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Waveguide Aerials (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Non-Reversible Transmitting Devices (AREA)
  • Control Of Motors That Do Not Use Commutators (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Indole Compounds (AREA)
NL9200423A 1991-03-08 1992-03-06 Farmaceutische samenstelling die als aktieve ingredient 3-/2-(dimethylamino)-ethyl/-n-methyl-1h-indool-5-methaansulfonamide bevat. NL9200423A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919104890A GB9104890D0 (en) 1991-03-08 1991-03-08 Compositions
GB9104890 1991-03-08

Publications (1)

Publication Number Publication Date
NL9200423A true NL9200423A (nl) 1992-10-01

Family

ID=42342461

Family Applications (1)

Application Number Title Priority Date Filing Date
NL9200423A NL9200423A (nl) 1991-03-08 1992-03-06 Farmaceutische samenstelling die als aktieve ingredient 3-/2-(dimethylamino)-ethyl/-n-methyl-1h-indool-5-methaansulfonamide bevat.

Country Status (29)

Country Link
US (4) US5863559A (de)
EP (1) EP0503440B1 (de)
JP (1) JP2986546B2 (de)
KR (1) KR100202042B1 (de)
AT (1) ATE165973T1 (de)
AU (1) AU663303B2 (de)
BE (1) BE1005086A5 (de)
CA (1) CA2105180C (de)
CH (1) CH684242A5 (de)
CY (1) CY2011A (de)
CZ (1) CZ282352B6 (de)
DE (1) DE69225421T2 (de)
DK (1) DK0503440T3 (de)
ES (1) ES2117015T3 (de)
FR (1) FR2673538B1 (de)
GB (2) GB9104890D0 (de)
GE (1) GEP20012549B (de)
HK (1) HK19395A (de)
IE (1) IE920726A1 (de)
IL (1) IL101162A (de)
IT (1) IT1271495B (de)
MX (1) MX9200992A (de)
NL (1) NL9200423A (de)
NZ (1) NZ241873A (de)
OA (1) OA09812A (de)
RU (1) RU2098093C1 (de)
SG (1) SG169294G (de)
WO (1) WO1992015295A1 (de)
ZA (1) ZA921690B (de)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9104890D0 (en) * 1991-03-08 1991-04-24 Glaxo Group Ltd Compositions
EP0546593B1 (de) * 1991-10-30 1997-09-03 Glaxo Group Limited Mehrschichtzusammensetzungen enthaltend Histamin- oder Serotonin- Antagonisten
DE4314976C1 (de) * 1993-05-06 1994-10-06 Lohmann Therapie Syst Lts Transdermale therapeutische Systeme zur Verabreichung von Wirkstoffen, Verfahren zu ihrer Herstellung und ihre Verwendung
US8022095B2 (en) * 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
US6066092A (en) * 1997-11-06 2000-05-23 Cady; Roger K. Preemptive prophylaxis of migraine device and method
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
GB9924717D0 (en) * 1999-10-19 1999-12-22 Glaxo Group Ltd Diagnostic
AT500063A1 (de) 1999-11-23 2005-10-15 Sandoz Ag Beschichtete tablettenkerne
WO2002026210A2 (en) * 2000-09-29 2002-04-04 Geneva Pharmaceuticals Inc. Proton pump inhibitor formulation
US20030070584A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
AU4061702A (en) * 2001-05-15 2003-04-03 Mcneil-Ppc, Inc. Dip coating compositions containing starch or dextrin
US20030013753A1 (en) * 2001-06-05 2003-01-16 Ronald Aung-Din Transdermal migraine therapy
US8329734B2 (en) * 2009-07-27 2012-12-11 Afgin Pharma Llc Topical therapy for migraine
US8309118B2 (en) * 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
GB0129117D0 (en) * 2001-12-05 2002-01-23 Glaxo Group Ltd Pharmaceutical composition
US20040052843A1 (en) * 2001-12-24 2004-03-18 Lerner E. Itzhak Controlled release dosage forms
US20030228363A1 (en) * 2002-06-07 2003-12-11 Patel Mahendra R. Stabilized pharmaceutical compositons containing benzimidazole compounds
RU2005104827A (ru) * 2002-07-19 2006-07-27 Рэнбакси Лабораториз Лимитед (In) Таблетки суматриптана с замаскированным вкусом и способы их получения
US7429619B2 (en) * 2002-08-02 2008-09-30 Mcneil Consumer Healthcare Polyacrylic film forming compositions
US20040068000A1 (en) * 2002-10-02 2004-04-08 Mintong Guo Compression coated tablets
ES2380827T3 (es) * 2002-12-26 2012-05-18 Pozen, Inc. Formas de dosificación con múltiples capas que contienen naproxeno y triptanes
US20080213363A1 (en) * 2003-01-23 2008-09-04 Singh Nikhilesh N Methods and compositions for delivering 5-HT3 antagonists across the oral mucosa
WO2004076403A1 (en) * 2003-02-24 2004-09-10 Transform Pharmaceuticals, Inc. Sumatriptan crystalline forms, pharmaceutical compositions and methods
BRPI0410807A (pt) * 2003-06-06 2006-06-27 Glaxo Group Ltd composição farmacêutica, e, método pata tratar um mamìfero sofrendo de ou susceptìvel a condições associadas com dor cefálica
EP1644004A4 (de) 2003-06-20 2010-10-06 Ronald Aung-Din Topische therapie zur behandlung von migräne, muskelzerrungen, muskelspasmus, spastizität und verwandten zuständen
GB2407498B (en) * 2003-10-30 2008-06-11 Cipla Ltd Oral formulations for 5-HT receptor agonists with reduced degradation of active ingredient
GB0400452D0 (en) * 2004-01-09 2004-02-11 Norton Healthcare Ltd A pharmaceutical composition
GB0403628D0 (en) * 2004-02-18 2004-03-24 Arrow Group Ltd Compression-coated tablets and the manufacture thereof
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
EP3216445A1 (de) * 2004-05-28 2017-09-13 Imaginot Pty Ltd. Abgabesystem für eine orale therapeutische verbindung
US20060002989A1 (en) * 2004-06-10 2006-01-05 Ahmed Salah U Formulations of sumatriptan for absorption across biological membranes, and methods of making and using the same
MY147767A (en) 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
CA2609185A1 (en) 2005-05-20 2006-11-30 Ahmed F. Abdel-Magid Process for preparation of sulfamide derivatives
EP3263117A1 (de) * 2005-11-28 2018-01-03 Imaginot Pty Ltd. Abgabesystem für eine orale therapeutische verbindung
WO2007070504A2 (en) * 2005-12-13 2007-06-21 Morton Grove Pharmaceuticals, Inc. Stable and palatable oral liquid sumatriptan compositions
US8492431B2 (en) 2005-12-19 2013-07-23 Janssen Pharmaceutica, N.V. Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity
US8691867B2 (en) 2005-12-19 2014-04-08 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
US8937096B2 (en) 2005-12-19 2015-01-20 Janssen Pharmaceutica Nv Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
US8716231B2 (en) 2005-12-19 2014-05-06 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
US8497298B2 (en) 2005-12-19 2013-07-30 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
RU2313340C1 (ru) * 2006-02-20 2007-12-27 Дмитрий Владимирович Зимин Лекарственное средство, обладающее противомигренозным действием, и способ его изготовления
AU2007253814A1 (en) 2006-05-19 2007-11-29 Janssen Pharmaceutica N.V. Co-therapy for the treatment of epilepsy
US8653066B2 (en) 2006-10-09 2014-02-18 Charleston Laboratories, Inc. Pharmaceutical compositions
WO2008049116A2 (en) 2006-10-19 2008-04-24 Auspex Pharmaceuticals, Inc. Substituted indoles
EP2240022B1 (de) 2008-01-09 2016-12-28 Charleston Laboratories, Inc. Oxycodone und Promethazine enthaltende zweischichtige Tabletten
US20090252791A1 (en) * 2008-04-02 2009-10-08 Venkata Nookaraju Sreedharala Pharmaceutical compositions comprising a triptan and a nonsteroidal anti-inflammatory drug
RU2424803C2 (ru) * 2008-04-07 2011-07-27 Учреждение Российской академии медицинских наук Научно-исследовательский институт фармакологии имени В.В. Закусова РАМН (НИИ фармакологии имени В.В.Закусова РАМН) Фармацевтическая композиция с противомигреневым действием (варианты)
AU2009260166B2 (en) * 2008-06-20 2014-10-09 Alphapharm Pty Ltd Pharmaceutical formulation
WO2010008776A2 (en) 2008-06-23 2010-01-21 Janssen Pharmaceutica Nv Disposable patch and reusable sensor assembly for use in medical device localization and mapping systems
CA2729346A1 (en) * 2008-06-30 2010-01-14 Afgin Pharma, Llc Topical regional neuro-affective therapy
US8815939B2 (en) 2008-07-22 2014-08-26 Janssen Pharmaceutica Nv Substituted sulfamide derivatives
EP2451274B1 (de) 2009-07-08 2017-10-04 Charleston Laboratories, Inc. Pharmazeutische zusammensetzungen
US11337962B2 (en) 2009-09-25 2022-05-24 Upsher-Smith Laboratories, Llc Formulations comprising triptan compounds
NZ599344A (en) 2009-09-25 2015-02-27 Reddy’S Lab Ltd Dr Formulations comprising triptan compounds
US10383816B2 (en) 2015-03-02 2019-08-20 Afgin Pharma, Llc Topical regional neuro-affective therapy with cannabinoid combination products
BR112017018944A2 (en) 2015-03-02 2018-05-15 Afgin Pharma, Llc method of treating a disease state or condition in humans with a carbinoid drug, and method of treating a disease state or condition in a mammal other than a human with carbinoid drug (s)
US10179109B2 (en) 2016-03-04 2019-01-15 Charleston Laboratories, Inc. Pharmaceutical compositions comprising 5HT receptor agonist and antiemetic particulates
US20180049994A1 (en) 2016-08-16 2018-02-22 Afgin Pharma, Llc Topical regional neuro-affective therapy with caryophyllene

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR79215B (de) * 1982-06-07 1984-10-22 Glaxo Group Ltd
GB8332437D0 (en) * 1983-12-06 1984-01-11 Glaxo Group Ltd Chemical compounds
GB2162522B (en) * 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative
GB8419575D0 (en) * 1984-08-01 1984-09-05 Glaxo Group Ltd Chemical compounds
GB8928208D0 (en) * 1989-12-13 1990-02-14 Glaxo Group Ltd Medicaments
GB9104890D0 (en) * 1991-03-08 1991-04-24 Glaxo Group Ltd Compositions

Also Published As

Publication number Publication date
ITRM920155A0 (it) 1992-03-06
GB2254784B (en) 1994-11-16
WO1992015295A1 (en) 1992-09-17
OA09812A (en) 1994-04-15
US5863559A (en) 1999-01-26
IL101162A (en) 1997-11-20
JP2986546B2 (ja) 1999-12-06
ITRM920155A1 (it) 1993-09-06
JPH06505020A (ja) 1994-06-09
ATE165973T1 (de) 1998-05-15
BE1005086A5 (fr) 1993-04-13
CA2105180A1 (en) 1992-09-09
IL101162A0 (en) 1992-11-15
CA2105180C (en) 1999-08-17
GEP20012549B (en) 2001-10-25
HK19395A (en) 1995-02-17
FR2673538B1 (fr) 1995-05-12
GB9204761D0 (en) 1992-04-15
DK0503440T3 (da) 1999-01-18
RU2098093C1 (ru) 1997-12-10
DE69225421T2 (de) 1998-10-15
ZA921690B (en) 1993-08-02
CH684242A5 (fr) 1994-08-15
CZ184993A3 (en) 1994-06-15
GB2254784A (en) 1992-10-21
IT1271495B (it) 1997-05-30
CZ282352B6 (cs) 1997-07-16
AU1326492A (en) 1992-10-06
GB9104890D0 (en) 1991-04-24
EP0503440A1 (de) 1992-09-16
US6368627B1 (en) 2002-04-09
US6020001A (en) 2000-02-01
EP0503440B1 (de) 1998-05-13
NZ241873A (en) 1994-06-27
MX9200992A (es) 1992-09-01
DE69225421D1 (de) 1998-06-18
AU663303B2 (en) 1995-10-05
KR100202042B1 (ko) 1999-06-15
CY2011A (en) 1998-02-20
SG169294G (en) 1995-04-28
US20020197318A1 (en) 2002-12-26
FR2673538A1 (fr) 1992-09-11
ES2117015T3 (es) 1998-08-01
IE920726A1 (en) 1992-09-09

Similar Documents

Publication Publication Date Title
RU2098093C1 (ru) Фармацевтическая композиция на основе суматриптана
US6515010B1 (en) Carvedilol methanesulfonate
JP3636380B2 (ja) 二重層オキカルバゼピン錠剤
JP2528130B2 (ja) 経口投与形体の徐放性医薬組成物
TW550090B (en) Stable oral pharmaceutical dosage forms for acid-unstable drug
JP4159607B2 (ja) 大量の薬物を含有する速崩壊性及び速溶解性組成物製造のための顆粒
JP3725542B2 (ja) ピコサルフェート剤形
KR100421347B1 (ko) 약학 혼합 제제
KR100202154B1 (ko) 파라세타몰 및 돔페리돈을 함유한 필름 피복 정제
SK285152B6 (sk) Enterický potiahnutý farmaceutický prostriedok a spôsob jeho prípravy
EP1555022A1 (de) Verbindung von acetaminophenol und tramadol mit verzögerter freisetzung
JPH07223970A (ja) 消化管内適所放出製剤
WO2006082523A2 (en) Pharmaceutical sustained release composition of metformin
CN104363896A (zh) 恩替卡韦的药物组合物及制造方法
HU228040B1 (en) Coated trimebutine maleate tablet
AU2006213439A1 (en) Pharmaceutical composition of acid labile substances
JP2024009815A (ja) アキシチニブを含有する医薬組成物
WO2005084648A1 (en) Pharmaceutical compositions comprising candesartan cilexetil
JP2002518330A (ja) 処置方法
MXPA06010805A (es) Formulacion de claritromicina de libracion prolongada.
RU2464018C1 (ru) Фармацевтическая композиция для лечения сердца пролонгированного действия
JP2009525953A (ja) ジバルプロ酸及びその誘導体の徐放性製剤

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BN A decision not to publish the application has become irrevocable